Novartis East Hanover Announces Job Cuts at New Jersey Headquarters

Novartis East Hanover has announced layoffs affecting approximately 300 employees at its New Jersey headquarters. The job cuts are part of a broader restructuring effort aimed at streamlining operations and reducing costs. This decision comes amid ongoing challenges in the pharmaceutical industry, including increased competition and pressure to lower drug prices. The layoffs are expected to take effect immediately, impacting various departments within the company. Novartis has stated that these changes are necessary to maintain its competitive edge and ensure long-term sustainability.

LayoffTalk has tracked 24 layoff events at Novartis East Hanover since March 2025, including 234 jobs documented in official WARN filings, with 20 additional events known from news reporting.